<DOC>
	<DOC>NCT00490347</DOC>
	<brief_summary>The purpose of this trial is to determine the safety and feasibility of the VentrAssist LVAD in providing circulatory support for patients who require an LVAD as a bridge to cardiac transplantation.</brief_summary>
	<brief_title>VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Inclusion Criteria (The following are general criteria; more specific criteria are included in the study protocol): Approved and listed for cardiac transplantation. Patient for whom LVAD implantation is planned as a clinically indicated bridge to cardiac transplantation. Exclusion Criteria(The following are general criteria; more specific criteria are included in the study protocol): Presence of heart conditions that would contraindicate LVAD implantation by adversely affecting patient survival or LVAD function. Primary coagulopathy or platelet disorder; contraindication to anticoagulant or antiplatelet agents. Presence of any mechanical circulatory support other than intraaortic balloon pump. Therapy with an investigational intervention at the time of screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>VentrAssistTM</keyword>
	<keyword>LVAD</keyword>
	<keyword>End-stage heart failure</keyword>
	<keyword>Cardiomyopathy</keyword>
</DOC>